# US 2019/0376974 A1 · Method for acquiring medical care auxiliary information

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376974 A1
- Document ID: US20190376974A1
- Status: Published application
- Kind: A1
- Application number: 16/464,465
- Filed: 2017-11-29
- Published: 2019-12-12
- Earliest claimed: 2016-11-29
- Assignees: Konica Minolta, Inc.; Hirosaki University
- Applicants: Konica Minolta, Inc.; Hirosaki University
- Inventors: TOMONORI KANEKO; TAKATOSHI KAYA; CHIKARA OHYAMA; TOHRU YONEYAMA; YUKI TOBISAWA
- Web page: https://patentgrep.com/patent/US20190376974A1

## CPC

- G01N 33/57555: of the prostate
- G01N 1/30: Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis}
- G01N 33/66: involving blood sugars, e.g. galactose
- G01N 2001/302: {Stain compositions}
- G01N 2800/54: Determining the risk of relapse
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method for acquiring auxiliary information for diagnosis and treatment (medical care) of prostate cancer. A method for acquiring medical care auxiliary information for estimating a risk of prostate cancer recurrence with a specimen of prostate tissue, wherein an at least three-stage evaluation score is used to express a quantity of biological material in a tumor site of the specimen, the biological material having a β-N-acetylgalactosamine residue at a nonreducing terminal of a sugar chain.

## Claims

### Claim 1

A method for acquiring medical care auxiliary information for estimating a risk of prostate cancer recurrence with a specimen of prostate tissue,
wherein an at least three-stage evaluation score is used to express a quantity of biological material in a tumor site of the specimen, the biological material having a β-N-acetylgalactosamine residue at a nonreducing terminal of a sugar chain.

### Claim 2 (depends on 1)

The method for acquiring medical care auxiliary information according to claim 1, wherein, when a quantity of biological material is equal to or more than a threshold, the biological material is classified into a grade group with high recurrence risk of the evaluation score, and when a quantity of biological material is less than the threshold, the biological material is classified into a grade group with low recurrence risk of the evaluation score.

### Claim 3 (depends on 1)

The method for acquiring medical care auxiliary information according to claim 1, wherein the evaluation score is obtained in regard to a stained specimen which is prepared by a staining method that involves binding a molecule having an affinity for a β-N-acetylgalactosamine residue to the biological material.

### Claim 4 (depends on 3)

The method for acquiring medical care auxiliary information according to claim 3, wherein the molecule having an affinity for a β-N-acetylgalactosamine residue is Wisteria floribunda lectin (WFA), Soybean Agglutinin (SBA) or Vicia Villosa Lectin (VVL), or an anti-β-N-acetylgalactosamine antibody.

### Claim 5 (depends on 3)

The method for acquiring medical care auxiliary information according to claim 3, wherein the staining method is performed by the Avidin Biotinylated Enzyme Complex (ABC) method.

### Claim 6 (depends on 1)

The method for acquiring medical care auxiliary information according to claim 1, the method comprising
estimating a risk of prostate cancer recurrence by combining at least one piece of information selected from a group consisting of age, Gleason score (GS) or grade group (GG), pathological staging (pT), resection margin (RM), and perineural invasion (pn) obtained from the specimen or a patient from whom the specimen is taken.

### Claim 7 (depends on 2)

The method for acquiring medical care auxiliary information according to claim 2, wherein the evaluation score is obtained in regard to a stained specimen which is prepared by a staining method that involves binding a molecule having an affinity for a β-N-acetylgalactosamine residue to the biological material.

### Claim 8 (depends on 2)

The method for acquiring medical care auxiliary information according to claim 2, the method comprising
estimating a risk of prostate cancer recurrence by combining at least one piece of information selected from a group consisting of age, Gleason score (GS) or grade group (GG), pathological staging (pT), resection margin (RM), and perineural invasion (pn) obtained from the specimen or a patient from whom the specimen is taken.

### Claim 9 (depends on 3)

The method for acquiring medical care auxiliary information according to claim 3, the method comprising
estimating a risk of prostate cancer recurrence by combining at least one piece of information selected from a group consisting of age, Gleason score (GS) or grade group (GG), pathological staging (pT), resection margin (RM), and perineural invasion (pn) obtained from the specimen or a patient from whom the specimen is taken.

### Claim 10 (depends on 4)

The method for acquiring medical care auxiliary information according to claim 4, wherein the staining method is performed by the Avidin Biotinylated Enzyme Complex (ABC) method.

### Claim 11 (depends on 4)

The method for acquiring medical care auxiliary information according to claim 4, the method comprising
estimating a risk of prostate cancer recurrence by combining at least one piece of information selected from a group consisting of age, Gleason score (GS) or grade group (GG), pathological staging (pT), resection margin (RM), and perineural invasion (pn) obtained from the specimen or a patient from whom the specimen is taken.

### Claim 12 (depends on 5)

The method for acquiring medical care auxiliary information according to claim 5, the method comprising
estimating a risk of prostate cancer recurrence by combining at least one piece of information selected from a group consisting of age, Gleason score (GS) or grade group (GG), pathological staging (pT), resection margin (RM), and perineural invasion (pn) obtained from the specimen or a patient from whom the specimen is taken.
